In fact, the individuals with familial renal glucosuria, a genetic loss of SGLT2 function, do not generally suffer from hypoglycemia, an observation which supports the safety of the use of SGLT2 inhibitors [186]. The gene discussed is SLC5A2; the disease is Renal glucosuria.